Search results
This study aims to measure immunoglobulin G (IgG) and immunoglobulin M (IgM) response after detection of Severe Acute Respiratory Syndrome coronavirus (SARS CoV-2) antigens in coronavirus disease 2019 (COVID-19) patients concerning the severity of symptoms.
29 kwi 2020 · We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within 19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G (IgG)....
Here, we retrospectively described the dynamic changes of serum immunoglobulin M (IgM) and IgG specifically against SARS‐CoV‐2 in later weeks (mainly 4‐10 weeks) in 97 hospitalized patients with COVID‐19.
6 maj 2020 · This study aimed to determine the IgM and IgG responses against severe acute respiratory syndrome coronavirus (SARS-CoV)-2 in coronavirus disease 2019 (COVID-19) patients with varying illness severities.
25 sty 2022 · We discover an immunoglobulin (Ig) signature, based on total IgM and IgG3 levels, which – combined with age, history of asthma bronchiale, and five symptoms during primary infection – is able...
1 lip 2023 · The seroprevalence of SARS-CoV-2 IgM and IgG in COVID-19 patients was 81 and 83% less than 7 days after symptom onset, both antibodies raised to 95% at 2 weeks. Approximately 8% of COVID-19 patients tested negative for IgM or IgG .
22 gru 2022 · This study aimed to determine the levels of IgM and IgG antibody response to the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 in coronavirus disease 2019 (COVID-19) patients with different disease severity. Methods. IgM and IgG antibody levels were evaluated via enzyme-linked immunosorbent assay (ELISA).
